Memorial Sloan Kettering Cancer Center
M

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on Angiokinase Inhibitors, Immunotherapy Options, and Combination Strategies?

By Memorial Sloan Kettering Cancer Center FEATURING Marjorie Zauderer
By Memorial Sloan Kettering Cancer Center FEATURING Marjorie Zauderer
0 views
May 25, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Recommended

AUTOPLAY
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
22:27
2024 ASCO® Annual Meeting Insights Hub

Developmental Therapeutics Highlights From ASCO® 2024

Feat. G. Sonpavde
12:10
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "BEAT Trials and Neoadjuvant Strategies - A…

Feat. M. Marmarelis
04:35
Total Health

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Feat. J. Bauman
08:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "MIST5 Trial - Niraparib & Dostarlimab…

Feat. D. Fennell
15:37
ImmunoTherapy Bridge 2023

What’s New in NSCLC & Mesothelioma Immunotherapy

Feat. A. Morabito
11:28
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ETOP 13-18 BEAT-meso Trial - Bevacizumab …

Feat. S. Popat
08:14
2023 Texas Lung Cancer Conference Coverage

Updates in Malignant Pleural Mesothelioma

Feat. M. Marmarelis
09:04
Oncology Data Advisor

Discovering Research Advances in Mesothelioma

Feat. S. Kareff, E. Rodriguez
22:02
OncoAlert

Significant Advances in Mesothelioma

Feat. G. Mountzios
07:11
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "First Survival Data From the NIPU Trial - …

Feat. A. Helland
09:57
ILCC 2022 Conference Coverage

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

Feat. P. Baas
08:40
Laura Ridolfi

MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Adv…

10:31
MI&T Congressi

Immunotherapy for Patients With Mesothelioma

Feat. J. Aerts
05:39
GRACE

ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"

Feat. J. West, C. Lovly, A. Addeo
05:22
ecancer

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

Feat. S. Peters
04:33
ecancer

ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…

Feat. P. Bradbury
09:56
2020 Virtual ESMO Review

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…

Feat. M. Dietrich
16:56
WCLC 2022 Conference Coverage

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…

Feat. M. Jakopovic
21:36
2021 Virtual ESMO Review

ESMO 2021 Highlights on Stage III NSCLC and Malignant Mesothelioma: …

Feat. T. Owonikoko